Glory Health Industry (SEHK:2329) - Aktienkurs, Nachrichten und Analyse

2329 Aktienübersicht

Glory Health Industry Limited, eine Investment-Holdinggesellschaft, entwickelt und betreibt Immobilien in der Volksrepublik China.

Über das Unternehmen

2329 grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	4/6
Künftiges Wachstum	0/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	3/6
Dividenden	0/6

Belohnungen

85.9% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Risikoanalyse

Stark schwankender Aktienkurs in den letzten 3 Monaten

Die Verschuldung ist durch den operativer Cashflow nicht gut gedeckt

Die Erträge sind in den letzten 5 Jahren um 68.3% pro Jahr zurückgegangen

Hat keine nennenswerte Marktkapitalisierung (HK$476M)

Glory Health Industry Limited Wettbewerber

China Aoyuan Group

SEHK:3883

HK$565.2m

Central China Real Estate

SEHK:832

HK$358.6m

Central China Management

SEHK:9982

HK$425.2m

Weiye Holdings

SEHK:1570

HK$617.8m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Glory Health Industry
Historische Aktienkurse
Aktueller Aktienkurs	HK$0.10
52-Wochen-Hoch	HK$0.25
52-Wochen-Tief	HK$0.021
Beta	-0.068
11 Monat Veränderung	-11.02%
3 Monate Veränderung	262.07%
1 Jahr Veränderung	-38.60%
33 Jahre Veränderung	-74.70%
5 Jahre Veränderung	-92.86%
Veränderung seit IPO	-95.80%

Aktuelle Nachrichten und Updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Aktionärsrenditen

	2329	HK Real Estate	HK Markt
7D	-2.8%	-1.6%	-1.0%
1Y	-38.6%	-28.2%	0.7%

Rendite im Vergleich zur Industrie: 2329 unter dem Niveau der Branche Hong Kong Real Estate , die im vergangenen Jahr eine Rendite von -28% erzielte.

Rendite vs. Markt: 2329 hinter dem Markt Hong Kong zurück, der im vergangenen Jahr eine Rendite von -1.8 erzielte.

Preisvolatilität

Is 2329's price volatile compared to industry and market?
2329 volatility
2329 Average Weekly Movement	41.6%
Real Estate Industry Average Movement	8.1%
Market Average Movement	7.0%
10% most volatile stocks in HK Market	14.9%
10% least volatile stocks in HK Market	3.7%

Stabiler Aktienkurs: 2329Der Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: 2329Die wöchentliche Volatilität der Aktie ist im vergangenen Jahr von 29% auf 42% gestiegen.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1994	548	Zhangsun Zhang	www.glorypty.com

Glory Health Industry Limited, eine Investment-Holdinggesellschaft, entwickelt und betreibt Immobilien in der Volksrepublik China. Das Unternehmen ist in vier Segmenten tätig: Immobilienentwicklung, Bau und Erschließung von Primärgrundstücken, Immobilieninvestitionen sowie Immobilienverwaltung und damit verbundene Dienstleistungen. Das Segment Immobilienentwicklung entwickelt und verkauft Gewerbe- und Wohnimmobilien.

Glory Health Industry Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Glory Health Industry im Vergleich zum Marktanteil des Unternehmens?
2329 grundlegende Statistiken
Marktanteil	HK$466.66m
Gewinn(TTM)	-HK$606.00m
Umsatz(TTM)	HK$2.69b

0.2x

Kurs-Umsatz-Verhältnis

-0.8x

Kurs-Gewinn-Verhältnis

Ist 2329 zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
2329 Gewinn- und Verlustrechnung (TTM)
Einnahmen	CN¥2.51b
Kosten der Einnahmen	CN¥2.56b
Bruttogewinn	-CN¥50.28m
Sonstige Ausgaben	CN¥513.69m
Umsatz	-CN¥563.97m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.13
Bruttomarge	-2.01%
Nettogewinnspanne	-22.50%
Schulden/Eigenkapital-Verhältnis	160.9%

Wie hat sich 2329 auf lange Sicht entwickelt?

Historische Performance und Vergleiche

2329 Aktienübersicht

Belohnungen

Risikoanalyse

Glory Health Industry Limited Wettbewerber

SEHK:3883

HK$565.2m

SEHK:832

HK$358.6m

SEHK:9982

HK$425.2m

SEHK:1570

HK$617.8m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

Glory Health Industry Limited's Grundlagenzusammenfassung

0.2x

-0.8x

Erträge & Einnahmen